Detection of Barrett s Esophagus in Patients Without GERD Symptoms
NCT04880044 is an interventional trial sponsored by Case Comprehensive Cancer Center. As of 21 Nov 2026, it is completed. It studies Barrett's Esophagus. The registry lists an enrollment of 132 participants at 1 site in 1 country. The registry lists a start date of 5 Jan 2022 and a primary completion date of 25 Feb 2025. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04880044 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Case Comprehensive Cancer Center |
| Enrollment | 132 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Barrett's Esophagus |
| Start | 5 Jan 2022 |
| Primary completion | 25 Feb 2025 |
| Study completion | 25 Feb 2025 |
| Last update posted | 10 Mar 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Amitabh Chak, MD
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04880044
Each answer restates registry values shown on this page.
What is NCT04880044?
NCT04880044 is an interventional trial sponsored by Case Comprehensive Cancer Center. It studies Barrett's Esophagus.
Who leads NCT04880044?
The registry names Amitabh Chak, MD (principal investigator, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center) as the overall official.
Where does NCT04880044 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT04880044 end?
The registry lists a primary completion date of 25 Feb 2025 and a study completion date of 25 Feb 2025. The sponsor last updated the record on 10 Mar 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.